A European multi-city study shows an increase in illicit drugs or metabolites in waste water. Berlin was far ahead of other German cities for cocaine consumption.
The placenta and endometrium react to maternal infections and antidepressants with immunological changes that can influence neurodevelopment.
A minimum unit pricing legislation is associated with a significant reduction in alcohol-related deaths among people from the most socio-economically disadvantaged areas.
According to a recent study, transgender women are at risk of prostate cancer, even after gender-confirming surgery. However, to date, they are not included in screening strategies.
The motto "one size fits all" no longer applies to breast cancer treatment. More attention goes to the right therapy for each case, as Dr Adrian Lee discusses.
Good news from gynaecological oncology: 30 to 40% of all patients with ovarian cancer are now long-term survivors. Dr Hannah Woopen describes how this development came about.
At this year's Charité Mayo Congress, one of the four congress days was dedicated to ovarian cancer. Leading oncology expert Dr Andrea Wahner-Hendrickson addressed the relevant aspect of disease recurrence.
With PARP inhibitors, the prognosis for ovarian cancer has improved significantly. How should a newly diagnosed high-grade malignancy be treated?
The latest findings in gynaecological oncology were discussed at the 12th Charité-Mayo Conference. Prof. Sehouli shared his congress' highlights.
How can the current "heart failure epidemic" be tackled? Prof. Dr Lars Maier provides an overview on the current state of affairs.
Cardiology is facing technical and financial challenges. Demographic change also demands a new way of thinking about the specialty.
The current European guidelines (from 2018) recommend a mild reduction of blood pressure in older patients. But other studies advocate alternatives.
The medical profession is potentially one of the most risky professions. Dr. Ulrike Bossmann pleaded for physicians' self care despite pressure and stress.
It has not yet been conclusively clarified why SGLT2 inhibitors are associated with good outcomes in heart failure with pEF. The most relevant mechanisms of action were presented at the DGK 2023.
Heart failure in type 2 diabetics is associated with a significant increase in mortality. The most important comorbidities in heart failure were presented at the DGK 2023.
The concept of dysproportional mitral regurgitation makes it now possible to optimise therapy through meaningful patient characterisation.
The ESC published four new guidelines in 2022. We present the most important take-aways, as presented in the German Cardiology Congress (DGK) 2023.
Haemophilia patients have relied on lifelong injections of the missing clotting factors. A single dose of a newly approved gen therapy could be sufficient.
Children with autoimmune diseases risk severe infections. The benefits of a COVID-19 vaccines for this group are still debated, but a recent study supports their use.
In people with psoriatic arthritis (PsA), it is not only the joints that suffer: bone fractures and falls also occur more frequently, a recent study shows.